Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 127 of 1,261
  1. US 11938147

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  2. US 11939604

    Modified cascade ribonucleoproteins and uses thereof

    Caribou Biosciences, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  3. US 11938174

    Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders

    Takeda Pharmaceutical Company Limited Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  4. US 11938148

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  5. US 11939383

    B7-H4 antibodies and methods and use thereof

    Five Prime Therapeutics, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  6. US 11939402

    Antifungal peptides, compounds including the same, and methods of use thereof

    Seton Hall University Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  7. US 11938177

    Peptide vaccine formulations and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  8. US 11939581

    Methods and compositions for targeting PD-L1

    Aligos Therapeutics, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  9. US 11939392

    CD123 binding proteins and related compositions and methods

    Aptevo Research and Development LLC Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  10. US 11939591

    Genetically modified MSC and therapeutic methods

    The Regents of the University of California Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  11. US 11939368

    QTY Fc fusion receptor proteins

    Avalon GloboCare Corp. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  12. US 11939363

    Translatable molecules and synthesis thereof

    ARCTURUS THERAPEUTICS, INC. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  13. US 11939379

    Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies

    The Regents of the University of California Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  14. US 11939596

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  15. US 11939317

    Amide compounds and method for making and using

    Rigel Pharmaceuticals, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  16. US 11939327

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  17. US 11939343

    Sting agonist compounds and methods of use

    Mersana Therapeutics, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  18. US 11939345

    Physiologically stable fluorophore and performing fluorescence probing

    Government of the United States of America, as represented by the Secretary of Commerce Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  19. US 11938182

    Halogenated xanthenes as vaccine adjuvants

    Provectus Pharmatech, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  20. US 11938089

    Medication delivery systems and methods

    Amphastar Pharmaceuticals, Inc. Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  21. US 11938150

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  22. US 11939365

    T cell receptors recognizing mutated P53

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  23. US 11938226

    Abiotic anti-VEGF nanoparticle

    The Regents of the University of California Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted
  24. US 11939340

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated Β· Granted Mar 26, 2024 Β· Expires Mar 21, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.